Egetis Therapeutics AB Stock
Stocks
EGTX
SE0003815604
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.280 SEK | 0.00% |
|
+6.26% | +17.60% |
| Market Cap | 2.92B 303M 265M 245M 225M 425M 29.18B 433M 1.15B 14.25B 1.14B 1.11B 49.2B | P/E 2026 * |
552x | P/E 2027 * | -19.1x |
|---|---|---|---|---|---|
| Enterprise Value | 2.43B 252M 220M 204M 187M 354M 24.26B 360M 954M 11.85B 946M 925M 40.91B | EV / Sales 2026 * |
5.53x | EV / Sales 2027 * | 7.33x |
| Free-Float |
40.16% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Egetis Therapeutics AB
| 1 day | +0.64% | ||
| 1 week | +6.26% | ||
| Current month | +6.44% | ||
| 1 month | +17.16% | ||
| 3 months | +9.03% | ||
| 6 months | +40.34% | ||
| Current year | +17.60% |
| 1 week | 6.05 |  | 6.44 |
| 1 month | 5.17 | | 6.44 |
| Current year | 4.23 | | 7 |
| 1 year | 3.62 | | 7.07 |
| 3 years | 3.02 | | 9.3 |
| 5 years | 3 | | 9.3 |
| 10 years | 3 | | 50.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 2017-06-15 | |
Yilmaz Mahshid
DFI | Director of Finance/CFO | 47 | 2017-12-30 |
Tiago Nune
CTO | Chief Tech/Sci/R&D Officer | - | 2026-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2016-12-31 | |
| Director/Board Member | 65 | 2016-12-31 | |
Mats Blom
CHM | Chairman | 61 | 2024-05-05 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/13/26 | Sell | Chief Operating Officer | -264,880 | 0.0670% | ||
| 5/13/26 | Sell | Chief Financial Officer | -153,631 | 0.0389% | ||
| 5/13/26 | Sell | Executive/Senior Manager | -158,928 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +6.26% | +21.47% | +59.80% | 303M | |
| -3.42% | +10.05% | +58.59% | +87.70% | 57.82B | |
| -0.05% | -6.20% | +55.97% | +124.61% | 53.71B | |
| -2.14% | -7.78% | +4.46% | +421.65% | 23.8B | |
| -0.47% | -2.11% | -17.25% | -15.41% | 23.26B | |
| -0.56% | +10.26% | +44.03% | -3.86% | 20.7B | |
| -0.29% | -0.08% | +38.91% | -27.98% | 17.81B | |
| -4.55% | -8.65% | +194.32% | +349.58% | 16.9B | |
| -2.61% | +8.99% | +46.11% | +691.67% | 16.36B | |
| +0.23% | -0.77% | +26.37% | +187.16% | 13.96B | |
| Average | -1.32% | +1.57% | +47.30% | +187.49% | 24.46B | |
| Weighted average by Cap. | -1.62% | +0.19% | +49.53% | +166.44% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 439M 45.52M 39.78M 36.79M 33.76M 63.9M 4.39B 65.01M 172M 2.14B 171M 167M 7.39B | 353M 36.59M 31.98M 29.58M 27.14M 51.37M 3.53B 52.26M 139M 1.72B 137M 134M 5.94B |
| Net income | 149M 15.46M 13.52M 12.5M 11.47M 21.71M 1.49B 22.09M 58.56M 728M 58.07M 56.79M 2.51B | -95.62M -9.92M -8.67M -8.02M -7.36M -13.92M -956M -14.17M -37.56M -467M -37.25M -36.43M -1.61B |
| Net Debt | -492M -51.06M -44.63M -41.27M -37.87M -71.68M -4.92B -72.93M -193M -2.4B -192M -188M -8.29B | -334M -34.65M -30.29M -28.01M -25.7M -48.65M -3.34B -49.49M -131M -1.63B -130M -127M -5.63B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-16 | SEK 6.280 | 0.00% | 133,514 |
| 26-07-15 | SEK 6.280 | +0.80% | 394,037 |
| 26-07-14 | SEK 6.230 | -0.32% | 218,927 |
| 26-07-13 | SEK 6.250 | +2.80% | 264,842 |
| 26-07-10 | SEK 6.080 | -0.33% | 491,456 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EGTX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
